NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
87 hedge funds and large institutions have $92.8M invested in Navidea Biopharmaceuticals Inc. in 2014 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
9% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 22
99% less call options, than puts
Call options by funds: $81K | Put options by funds: $12.2M
Holders
87
Holding in Top 10
1
Calls
$81K
Puts
$12.2M
Top Buyers
| 1 | +$1.14M | |
| 2 | +$473K | |
| 3 | +$216K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$183K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$165K |
Top Sellers
| 1 | -$6.25M | |
| 2 | -$4.6M | |
| 3 | -$837K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$494K |
| 5 |
Swiss National Bank
Zurich,
Switzerland
|
-$215K |